UBS Group AG - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is and the CUSIP is 00444T209. A total of 36 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$42
+75.0%
72
+227.3%
0.00%
Q2 2023$24
-99.5%
22
-99.7%
0.00%
Q1 2023$4,617
+8.8%
7,016
+273.8%
0.00%
Q4 2022$4,2421,8770.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 195,000$440,7000.06%
Values First Advisors, Inc. 36,979$83,5720.06%
Rock Springs Capital Management LP 316,460$715,2000.02%
ARMISTICE CAPITAL, LLC 367,102$829,6510.01%
Texas Capital Bank Wealth Management Services Inc 21,500$48,5900.01%
MayTech Global Investments, LLC 2,562$5,7900.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 12,370$27,9560.00%
Advisory Services Network, LLC 187$4230.00%
UBS Group AG 1,877$4,2420.00%
NewEdge Advisors, LLC 505$10.00%
View complete list of ACELRX PHARMACEUTICALS INC shareholders